Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Change in Cash (2016)

Lixte Biotechnology Holdings' Change in Cash history spans 7 years, with the latest figure at -$469842.0 for Q4 2016.

  • For Q4 2016, Change in Cash changed N/A year-over-year to -$469842.0; the TTM value through Dec 2016 reached $174648.0, changed N/A, while the annual FY2025 figure was $4.1 million, 228.55% up from the prior year.
  • Change in Cash reached -$469842.0 in Q4 2016 per LIXT's latest filing, down from $573995.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $2.1 million in Q2 2012 to a low of -$469842.0 in Q4 2016.
  • Average Change in Cash over 5 years is $261036.8, with a median of $91042.0 recorded in 2015.
  • Peak YoY movement for Change in Cash: surged 6057.62% in 2012, then plummeted 616.03% in 2013.
  • A 5-year view of Change in Cash shows it stood at -$295888.0 in 2012, then surged by 260.54% to $475019.0 in 2013, then crashed by 175.7% to -$359579.0 in 2014, then soared by 125.32% to $91042.0 in 2015, then crashed by 616.07% to -$469842.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Change in Cash are -$469842.0 (Q4 2016), $573995.0 (Q3 2016), and -$25195.0 (Q2 2016).